Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Brian_O’Callaghan
|
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:developedBy |
therapies for endometriosis
therapies for preterm labor therapies for uterine fibroids |
| gptkbp:focusesOn |
women's reproductive health
|
| gptkbp:foundedIn |
2012
|
| gptkbp:founder |
gptkb:Ernest_Loumaye
|
| gptkbp:headquartersLocation |
gptkb:Geneva,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
ObsEva
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:status |
gptkb:public_company
|
| gptkbp:stockSymbol |
gptkb:OBSV
|
| gptkbp:website |
https://www.obseva.com/
|
| gptkbp:bfsParent |
gptkb:Frank_Verwiel
gptkb:Sofinnova_Investments |
| gptkbp:bfsLayer |
6
|